Cited by 129Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsCognitive Functions and Memory

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Decline in verbal memory during preclinical Alzheimer's disease: Examination of the effect of APOE genotype

LANGE, KELLY L., BONDI, MARK W., SALMON, DAVID P., GALASKO, DOUGLAS, DELIS, DEAN C., THOMAS, RONALD G., THAL, LEON J.·2002·Journal of the International Neuropsychological Society

DOI 10.1017/s1355617702870096

Open this paper in CoChat — free account

Abstract

A subtle decline in episodic memory often occurs prior to the emergence of the full dementia syndrome in nondemented older adults who develop Alzheimer's disease (AD). The APOE-ε4 genotype may engender a more virulent form of AD that hastens this decline. To examine this possibility, we compared the rate of decline in episodic memory during the preclinical phase of AD in individuals with or without at least one APOE ε4 allele. Nondemented normal control (NC; n = 84) participants, nondemented older adults who subsequently developed dementia within 1 or 2 years (i.e., preclinical AD; n = 20), and patients with mild AD (n = 53) were examined with 2 commonly employed tests of episodic memory, the Logical Memory subtest of the Wechsler Memory Scale–Revised and the California Verbal Learning Test. Results revealed a precipitous decline in verbal memory abilities 1 to 2 years prior to the onset of the dementia syndrome, but there was little effect of APOE genotype on the rate of this memory decline. The presence of an APOE-ε4 allele, however, did have a differential effect on the sensitivity of the 2 types of memory tests for tracking progression and made an independent contribution to the prediction of conversion to AD. (JINS, 2002, 8, 943–955.)

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1017/s1355617702870096

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

“Mini-mental state”
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
[Japanese version of the Neuropsychiatric Inventory--a scoring system for neuropsychiatric disturbance in dementia patients].
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,012
Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J., & Wouters, E. (2015) · Gerontology · doi:10.1159/000430949 · Cited by 19,852
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. J. (2014) · Gerontology · doi:10.1159/000362720 · Cited by 19,007
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Self-citation
Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Self-citation
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects
Blessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Measurement of Functional Activities in Older Adults in the Community
PFEFFER, R. I., Kurosaki, T., Harrah, C. H., Chance, J. M., & Filos, S. (1982) · Journal of Gerontology · doi:10.1093/geronj/37.3.323 · Cited by 2,978
Wechsler Memory Scale-Revised
Peter, H., Penzel, T., Peter, J. H., & Peter, J. G. (2025) · Springer Reference Medizin · doi:10.1007/978-3-662-65186-5_302294 · Cited by 2,278
Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.
Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.
Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9649 · Cited by 1,525
Patterns of Brain Activation in People at Risk for Alzheimer's Disease
Bookheimer, S. Y., Strojwas, M. H., Cohen, M. S., Saunders, A. M., Pericak-Vance, M. A., Mazziotta, J. C., & Small, G. W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430701 · Cited by 1,328
MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease
Jack, C. R., Petersen, R. C., O’Brien, P. C., & Tangalos, E. G. (1992) · Neurology · doi:10.1212/wnl.42.1.183 · Cited by 880
Alzheimer's disease
Katzman, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604103141506 · Cited by 801
Apolipoprotein E Status as a Predictor of the Development of Alzheimer's Disease in Memory-Impaired Individuals
Petersen, R. C. (1995) · JAMA · doi:10.1001/jama.1995.03520400044042 · Cited by 783
Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment
DeKosky, S. T., Ikonomovic, M. D., Styren, S. D., Beckett, L., Wisniewski, S., Bennett, D. A., Cochran, E. J., Kordower, J. H., & Mufson, E. J. (2002) · Annals of Neurology · doi:10.1002/ana.10069 · Cited by 686
Prediction of probable Alzheimer's disease in memory-impaired patients
Tierney, M. C., Szalai, J. P., Snow, W. G., Fisher, R. H., Nores, A., Nadon, G., Dunn, E. M., & George‐Hyslop, P. S. (1996) · Neurology · doi:10.1212/wnl.46.3.661 · Cited by 575
Preclinical prediction of AD using neuropsychological tests
Albert, M., Moss, M. B., Tanzi, R. E., & JONES, K. (2001) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617701755105 · Cited by 532
Stability of the preclinical episodic memory deficit in Alzheimer's disease
Bäckman, L., Small, B. J., & Fratiglioni, L. (2001) · Brain · doi:10.1093/brain/124.1.96 · Cited by 449
The 'Preclinical Phase' of Probable Alzheimer's Disease
Linn, R. T. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540290075020 · Cited by 438
Hypothesis: Microtubule Instability and Paired Helical Filament Formation in the Alzheimer Disease Brain Are Related to Apolipoprotein E Genotype
Strittmatter, W. J., Weisgraber, K. H., Goedert, M., Saunders, A. M., Huang, D., Corder, E. H., Dong, L., Jakes, R., Alberts, M. J., Gilbert, J. R., et al. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1019 · Cited by 433
Neuropsychological detection and characterization of preclinical Alzheimer’s disease
Jacobs, D. M., Sano, M., Dooneief, G., Marder, K., Bell, K. L., & Stern, Y. (1995) · Neurology · doi:10.1212/wnl.45.5.957 · Cited by 409
Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease
Gomez‐Isla, T., West, H. L., Rebeck, G. W., Harr, S. D., Growdon, J. H., Locascio, J. J., Perls, T. T., Lipsitz, L. A., & Hyman, B. T. (1996) · Annals of Neurology · doi:10.1002/ana.410390110 · Cited by 378
Temporal Lobe Regions on Magnetic Resonance Imaging Identify Patients With Early Alzheimer's Disease
Killiany, R., Moss, M. B., Albert, M., Sándor, T., Tieman, J., & Jolesz, F. A. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540090052010 · Cited by 371
Patterns of Cognitive Decline in Presymptomatic Alzheimer Disease
Chen, P., Ratcliff, G. G., Belle, S. H., Cauley, J. A., DeKosky, S. T., & Ganguli, M. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.9.853 · Cited by 369
The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment
Collie, A., & Maruff, P. T. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00012-9 · Cited by 339
The Course of Cognitive Impairment in Preclinical Alzheimer Disease: Three- and 6-Year Follow-up of a Population-Based Sample
Small, B. J., Fratiglioni, L., Viitanen, M., Winblad, B., & Bäckman, L. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.839 · Cited by 329
A Prospective Study of Cognitive Function and Onset of Dementia in Cognitively Healthy Elders
Rubin, E. H., Storandt, M., Miller, J. P., Kinscherf, D. A., Grant, E., Morris, J. C., & Berg, L. (1998) · Archives of Neurology · doi:10.1001/archneur.55.3.395 · Cited by 321
Compensatory reallocation of brain resources supporting verbal episodic memory in Alzheimer's disease
Becker, J. T., Mintun, M. A., Aleva, K., Wiseman, M. B., Nichols, T. E., & DeKosky, S. T. (1996) · Neurology · doi:10.1212/wnl.46.3.692 · Cited by 242
Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease.
Bondi, M. W., Salmon, D. P., Galasko, D., Thomas, R. G., & Thal, L. J. (1999) · Psychology and Aging · doi:10.1037//0882-7974.14.2.295 · Cited by 235
Self-citation
The Functional Neuroanatomy of Episodic Memory: The Role of the Frontal Lobes, the Hippocampal Formation, and Other Areas
Desgranges, B., Baron, J., & Eustache, F. (1998) · NeuroImage · doi:10.1006/nimg.1998.0359 · Cited by 231
Cognitive Markers Preceding Alzheimer's Dementia in the Healthy Oldest Old
Howieson, D. B., Dame, A., Camicioli, R. M., Sexton, G. J., Payami, H., & Kaye, J. A. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb03091.x · Cited by 213
Apolipoprotein E and cognitive change in an elderly population
Hyman, B. T., Gómez‐Isla, T., Briggs, M. E., Chung, H., Nichols, S., Kohout, F. J., & Wallace, R. B. (1996) · Annals of Neurology · doi:10.1002/ana.410400111 · Cited by 205
Learning and retention in preclinical and early Alzheimer's disease.
Grober, E. H., & Kawas, C. H. (1997) · Psychology and Aging · doi:10.1037//0882-7974.12.1.183 · Cited by 203
Sixteen-year longitudinal and time lag changes in memory and cognition in older adults.
Zelinski, E. M., & Burnight, K. P. (1997) · Psychology and Aging · doi:10.1037//0882-7974.12.3.503 · Cited by 190
Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., Tanzi, R. E., et al. (1995) · Neurology · doi:10.1212/wnl.45.7.1323 · Cited by 169
Object-memory evaluation for prospective detection of dementia in normal functioning elderly: Predictive and normative data
Fuld, P. A., Masur, D. M., Blau, A. D., Crystal, H., & Aronson, M. K. (1990) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688639008400998 · Cited by 167
Apolipoprotein E genotype influences cognitive ‘phenotype’ in patients with Alzheimer's disease but not in healthy control subjects
Smith, G. E., Bohac, D. L., Waring, S. C., Kokmen, E., Tangalos, E. G., Ivnik, R. J., & Petersen, R. C. (1998) · Neurology · doi:10.1212/wnl.50.2.355 · Cited by 167
Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation
Ohm, T. G., Kirca, M., Bohl, J., Scharnagl, H., Groβ, W., & März, W. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00596-w · Cited by 157
Memory performance in healthy elderly without Alzheimer’s disease: effects of time and apolipoprotein-E
Mayeux, R. P., Small, S. A., Tang, M., Tycko, B., & Stern, Y. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00223-8 · Cited by 156
Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease
Growdon, J. H., Locascio, J. J., Corkin, S., Gómez‐Isla, T., & Hyman, B. T. (1996) · Neurology · doi:10.1212/wnl.47.2.444 · Cited by 153
Accelerated decline in apolipoprotein E-ϵ4 homozygotes with Alzheimer's disease
Craft, S., Teri, L., Edland, S. D., Kukull, W. A., Schellenberg, G., McCormick, W. C., Bowen, J. D., & Larson, E. B. (1998) · Neurology · doi:10.1212/wnl.51.1.149 · Cited by 152
Gene dose of the ε4 allele of apolipoprotein E and disease progression in sporadic late‐onset alzheimer's disease
Frisoni, G. B., Govoni, S., Geroldi, C., Bianchetti, A., Calabresi, L., Franceschini, G., & Trabucchi, M. (1995) · Annals of Neurology · doi:10.1002/ana.410370509 · Cited by 149
APOE-ε4 is associated with memory decline in cognitively impaired elderly
Dik, M. G., Jonker, C., Bouter, L. M., Geerlings, M. I., van Kamp, G. J., & Deeg, D. J. H. (2000) · Neurology · doi:10.1212/wnl.54.7.1492 · Cited by 128
Evolution of Alzheimer’s disease related cortical lesions
Braak, H., Braak, E., Bohl, J. R. E., & Bratzke, H. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-7508-8_9 · Cited by 127
Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E ϵ4 allele
Soininen, H. S., Partanen, K. P. L., Pitkänen, A., Hallikainen, M., Hänninen, T., Helisalmi, S., Mannermaa, A., Ryynänen, M., Koiuisto, K., & Riekkinen, P. (1995) · Neurology · doi:10.1212/wnl.45.2.391 · Cited by 117
Specificity of Brain Activation Patterns in People at Genetic Risk for Alzheimer Disease
Burggren, A. C., Small, G. W., Sabb, F. W., & Bookheimer, S. Y. (2002) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200201000-00006 · Cited by 111
Apolipoprotein E Genotype and Rate of Decline in Probable Alzheimer's Disease
Forno, G. D., Rasmusson, D. X., Brandt, J., Carson, K. A., Brookmeyer, R., Troncoso, J., & Kawas, C. H. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550040085017 · Cited by 108
Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: a volumetric MRI study
Geroldi, C. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.1.93 · Cited by 106
Influences of cognitive support on episodic remembering: Tracing the process of loss from normal aging to Alzheimer's disease.
Bäckman, L., & Small, B. J. (1998) · Psychology and Aging · doi:10.1037//0882-7974.13.2.267 · Cited by 91
Apolipoprotein E, memory and Alzheimer's disease
Soininen, H. S., & Riekkinen, P. J. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10027-8 · Cited by 90
Apolipoprotein E epsilon 4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease
Kurz, A., Egensperger, R., Haupt, M., Lautenschlager, N. T., Romero, B., Graeber, M. B., & Müller, U. (1996) · Neurology · doi:10.1212/wnl.47.2.440 · Cited by 87
Neurological Findings in Alzheimer's Disease and Normal Aging
Galasko, D., Kwo-On-Yuen, P. F., Klauber, M. R., & Thal, L. J. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530060033012 · Cited by 85
Self-citation
Apolipoprotein ϵ4 allele and disease progression in patients with late-onset Alzheimer's disease
Basun, H., Grut, M., Winblad, B. G., & Lannfelt, L. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(94)11107-t · Cited by 84
Three-year changes in cognitive performance as a function of apolipoprotein E genotype: Evidence from very old adults without dementia.
Small, B. J., Basun, H., & Bäckman, L. (1998) · Psychology and Aging · doi:10.1037//0882-7974.13.1.80 · Cited by 81
The Progression of Alzheimer’s Disease from Limbic Regions to the Neocortex: Clinical, Radiological and Pathological Relationships
Nagy, Z., Hindley, N., Braak, H., Braak, E., Yilmazer‐Hanke, D., Schultz, C., Barnetson, L. P. D., KING, E., Jobst, K. A., & Smith, A. D. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017111 · Cited by 78
Epidemiological, Clinical, and Neuropathological Study of Apolipoprotein E Genotype in Alzheimer's Disease
Hyman, B. T., Gómez‐Isla, T., Rebeck, G. W., Briggs, M. E., Chung, H., WEST, H. L., Greenberg, S. M., Mui, S., NICHOLS, S., Wallace, R. B., et al. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb32592.x · Cited by 64
Apolipoprotein E Genotype and its Effect on Duration and Severity of Early and Late Onset Alzheimer's Disease
Norrman, J., Brookes, A. J., Yates, C. M., & Clair, D. S. (1995) · The British Journal of Psychiatry · doi:10.1192/bjp.167.4.533 · Cited by 33

Research works printed but not linked: 8

American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 4th ed. Author; Washington, DC: 1994. [Google Scholar]
Bondi MW, Monsch AU, Galasko D, Butters N, Salmon DP, Delis DC. Preclinical cognitive markers of dementia of the Alzheimer type. Neuropsychology. 1994;8:374–384. [Google Scholar]
DeKosky ST, Ferrell R, Kamboh MI, Becker JT. Natural history of definite AD as a function of APOE genotypes. Neurology. 1995;5(Suppl 4):A373. [Google Scholar]
Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test. The Psychological Corporation; New York: 1987. [Google Scholar]
Delis DC, Massman PJ, Butters N, Salmon DP, Kramer JH, Cermak L. Profiles of demented and amnesic patients on the CVLT: Implications for the assessment of memory disorders. Psychological Assessment. 1991;3:19–26. [Google Scholar]
Mattis S. Dementia Rating Scale: Professional manual. Psychological Assessment Resources; Odessa, FL: 1988. [Google Scholar]
Salmon DP, Bondi MW. Neuropsychology of Alzheimer disease. In: Terry RD, Katzman R, Bick KL, Sisodia SS, editors. Alzheimer disease. 2nd ed. Lippincott Williams & Wilkins; Philadelphia: 1999. pp. 39–56. [Google Scholar]
Salmon DP, Butters NM. Neuropsychologic assessment of dementia in the elderly. In: Katzman R, Rowe JW, editors. Principles of geriatric neurology. F.A. Davis; New York: 1992. pp. 144–163. [Google Scholar]

Sorted by citations

Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models
Webster, S. J., Bachstetter, A. D., Nelson, P. T., Schmitt, F. A., & Van Eldik, L. J. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00088 · Cited by 755
“Thus, great efforts have been made to better understand the proﬁle of cognitive deﬁcits associated with early AD, and have resulted in earlier and more reliable clinical diagnosis (Bondi et al., 1995, 1999; Jacobson et al., 2002; Lange et al., 2002; Mickes et al., 2007).”
Background
Neuropsychological Criteria for Mild Cognitive Impairment Improves Diagnostic Precision, Biomarker Associations, and Progression Rates
Bondi, M. W., Initiative, F. T. A. D. N., Edmonds, E. C., Jak, A. J., Clark, L. R., Delano-Wood, L., McDonald, C. R., Nation, D. A., Libon, D. J., Au, R., et al. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140276 · Cited by 772
Self-citation
Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis
Bäckman, L., Jones, S., Berger, A.-K., Laukka, E. J., & Small, B. J. (2005) · Neuropsychology · doi:10.1037/0894-4105.19.4.520 · Cited by 735
The Neuropsychological Profile of Alzheimer DiseasePreprint
Weıntraub, S., Wicklund, A. H., & Salmon, D. P. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006171 · Cited by 638
Self-citation
EFNS guidelines for the diagnosis and management of Alzheimer's disease
Hort, J., O’Brien, J. T., Gainotti, G., Pirttila, T., Popescu, B. O., Rektorova, I., Sorbi, S., Scheltens, P., & Dementia, O. B. O. T. E. S. P. O. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03040.x · Cited by 490

See all 129

Authors: LANGE, K. L., BONDI, M. W., SALMON, D. P., GALASKO, D., DELIS, D. C., THOMAS, R. G., & THAL, L. J.
Affiliations: San Diego State University (US)
University of California San Diego (US)
ORCID: BONDI, MARK W.
SALMON, DAVID P.
GALASKO, DOUGLAS
THOMAS, RONALD G.
Venue: Journal of the International Neuropsychological Society
Publisher: Cambridge University Press (CUP)
Published: 2002-11
Volume: 8
Issue: 7
Pages: 943-955
ISSN: 1355-6177 (ISSN-L)
1469-7661
DOI: 10.1017/s1355617702870096
OpenAlex: W2103898616
Cited by: 129
References: 64
Citations by year: 2026: 3 · 2025: 5 · 2024: 3 · 2023: 7 · 2022: 5 · 2021: 6 · 2020: 5 · 2019: 10 · 2018: 1 · 2017: 6 · 2016: 5 · 2015: 8 · 2014: 5 · 2013: 5 · 2012: 4
FWCI: 3.64
Type: journal article
Language: en
Open access: closed
Licence: www.cambridge.org/core/terms (unspecified, 12 d)
Locations: Journal of the International Neuropsychological Society (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Department of Veterans Affairs
American Psychological Association
National Institute on Aging (AG05131, P50AG005131, R56AG012674, R01AG012674, R29AG012674, AG12674)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Social Sciences › Psychology › Experimental and Cognitive Psychology › Cognitive Functions and Memory
Keywords: preclinical Alzheimer's disease, verbal memory decline, APOE ε4, episodic memory, conversion to dementia, mild cognitive impairment, California Verbal Learning Test, genetic risk factors, older adults
MeSH terms: Aged, Alleles, Alzheimer Disease, Apolipoproteins E, Female, Genotype, Humans, Male, Memory Disorders, Neuropsychological Tests, Severity of Illness Index, Vocabulary

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Decline in verbal memory during preclinical Alzheimer's disease: Examination of the effect of APOE genotype

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks